Paolo De Coppi

Paolo De Coppi is a leading Consultant Paediatric Surgeon and a prominent figure in stem cell and regenerative medicine, contributing significantly to advancements in treating complex congenital anomalies. After identifying the potential of amniotic fluid stem cells for therapeutic applications while working with Anthony Atala, M.D., at Boston Children’s Hospital, Paolo De Coppi went on to become a prominent figure in stem cell and regenerative medicine. This groundbreaking discovery, which identified the ability of these cells to differentiate into various tissues and restore functional activity in animal disease models, led to an international patent and was featured as the cover story of Nature Biotechnology in January 2007. Currently, Mr.

His current research efforts are directed towards developing reliable methods for the clinical isolation, expansion, and differentiation of stem cells. In 2024, Mr. De Coppi was named to TIME’s inaugural TIME100 Health List, recognizing his significant global impact on healthcare innovation. This accolade underscores his continued commitment to advancing stem cell and regenerative medicine, facilitating new approaches for correcting complex congenital malformations and improving outcomes for paediatric patients worldwide.